http://www.cbc.ca/news/health/story/...er-killer.html
Dandelion tea touted as possible cancer killer
Trials planned at Windsor Regional Cancer Centre in Ontario
CBC News
Posted: Feb 16, 2012 1:08 PM ET
Last Updated: Feb 16, 2012 2:16 PM ET
Researchers hope to test dandelion tea on patients at a Windsor, Ont., clinic after it was found the roots of the weed killed cancer cells in the laboratory.
The promising research is being led by a University of Windsor oncologist, in association with the Windsor Regional Cancer Centre.
Dr. Caroline Hamm said dandelion root extract is unique, and is one of the only things found to help with chronic myelomonocytic leukemia.
"It was really unusual to find a product that had efficacy in that area," said Hamm.
Some patients swear by it...
[snip]
The researchers have filed an application with Health Canada. If it's approved, Hamm expected to start the first phase of the trials in about two to three months.
Phase 1 involves 21 cancer patients where the standard of care is not working. Hamm said it would include patients with a wide variety of cancer types. The first phase should last six to eight months, she said.
Phase 2 will look at which types of cancer dandelion extract works best on, based on the results of Phase 1.
Trials planned at Windsor Regional Cancer Centre in Ontario
CBC News
Posted: Feb 16, 2012 1:08 PM ET
Last Updated: Feb 16, 2012 2:16 PM ET
Researchers hope to test dandelion tea on patients at a Windsor, Ont., clinic after it was found the roots of the weed killed cancer cells in the laboratory.
The promising research is being led by a University of Windsor oncologist, in association with the Windsor Regional Cancer Centre.
Dr. Caroline Hamm said dandelion root extract is unique, and is one of the only things found to help with chronic myelomonocytic leukemia.
"It was really unusual to find a product that had efficacy in that area," said Hamm.
Some patients swear by it...
[snip]
The researchers have filed an application with Health Canada. If it's approved, Hamm expected to start the first phase of the trials in about two to three months.
Phase 1 involves 21 cancer patients where the standard of care is not working. Hamm said it would include patients with a wide variety of cancer types. The first phase should last six to eight months, she said.
Phase 2 will look at which types of cancer dandelion extract works best on, based on the results of Phase 1.